Constellation Pharmaceuticals, Inc.
CNST
CNST was delisted on the 14th of July, 2021.
48 hedge funds and large institutions have $129M invested in Constellation Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 50 → 48 (-2)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
37% less capital invested
Capital invested by funds: $204M → $129M (-$74.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ROTUOC
Regents of the University of California
Oakland,
California
|
+$19.2M |
| 2 |
PS
Peter Svennilson
|
+$11.1M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$2.06M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$334K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2M |
| 2 |
DM
Deerfield Management
New York
|
-$1.34M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$488K |
| 4 |
First Eagle Investment Management
New York
|
-$350K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$282K |
CNST Hedge Fund Activity: Q3 2019 in Review
48 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2019, worth a combined $129M — down 37% from $204M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CNST and 5 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 18 added.
The largest buyer was Regents of the University of California, opening a new position worth an estimated $19.2M. The largest seller was Fidelity Investments, cutting an estimated $2M.
- 48 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2019, down from 50 in Q2 2019.
- Funds reported $129M of Constellation Pharmaceuticals, Inc. stock for Q3 2019, down 37% quarter-over-quarter.
- 5 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2019 and 6 closed out, a net change of -1 holder.
- The largest Constellation Pharmaceuticals, Inc. buyer in Q3 2019 was Regents of the University of California, an estimated $19.2M added.
- The largest Constellation Pharmaceuticals, Inc. seller in Q3 2019 was Fidelity Investments, an estimated $2M sold.
Based on aggregated 13F filings for Q3 2019.